Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 4/20 | 0.43 |
| ▸ | GALR2 | O43603 | 2/20 | 0.42 |
| ▸ | GALR1 | P47211 | 2/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3882315 | 0.93 | GALR2 (0.43) | HSD11B1GALR2GALR1EPHX2 | |
| SCHEMBL3880107 | 0.92 | HSD11B1 (0.43) | HSD11B1GALR2GALR1 | |
| SCHEMBL3889383 | 0.88 | HSD11B1 (0.48) | HSD11B1GALR2GALR1EPHX2 | |
| SCHEMBL3881062 | 0.87 | HSD11B1 (0.41) | HSD11B1GALR2GALR1 | |
| SCHEMBL3877649 | 0.87 | GALR2 (0.45) | HSD11B1GALR2GALR1EPHX2 | |
| SCHEMBL3879595 | 0.87 | HSD11B1 (0.45) | HSD11B1GALR2GALR1EPHX2 | |
| SCHEMBL3876550 | 0.87 | PHGDH (0.45) | HSD11B1GALR2GALR1EPHX2 | |
| SCHEMBL14583744 | 0.85 | TRPV1 (0.41) | HSD11B1GALR2GALR1 | |
| SCHEMBL3878640 | 0.85 | GALR2 (0.43) | HSD11B1GALR2GALR1EPHX2 | |
| SCHEMBL3888345 | 0.85 | HSD11B1 (0.42) | HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7566712-B2 | Biaryl piperazinyl-pyridine analogues | NEUROGEN CORPORATION (US) | 2009-07-28 | — | — | US | disclosed |
| US-7566712-B2 | Biaryl piperazinyl-pyridine analogues | NEUROGEN CORPORATION (US) | 2009-07-28 | — | — | US | disclosed |
| US-7566712-B2 | Biaryl piperazinyl-pyridine analogues | NEUROGEN CORPORATION (US) | 2009-07-28 | — | — | US | disclosed |